Mirioglu, S. Et Al. 2022. SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. ANNALS OF THE RHEUMATIC DISEASES , vol.81 , 1374.

Mirioglu, S., Cinar, S., Uludag, O., Gurel, E., Varelci, S., Ozluk, Y., ... Kilicaslan, I.(2022). SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1374.

Mirioglu, S. Et Al. "SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS," ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1374, 2022

Mirioglu, S. Et Al. "SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.1374, 2022

Mirioglu, S. Et Al. (2022) . "SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, p.1374.

@article{article, author={S. Mirioglu Et Al. }, title={SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={1374} }